• Nie Znaleziono Wyników

Professor Jarosław Sławek elected Secretary of the International Association of Parkinsonism and Related Disorders

N/A
N/A
Info
Pobierz
Protected

Academic year: 2022

Share "Professor Jarosław Sławek elected Secretary of the International Association of Parkinsonism and Related Disorders"

Copied!
1
0
0

Ładowanie.... (Zobacz pełny tekst teraz)

Pobierz teraz ( 1 Stron )

Pełen tekst

(1)

www.journals.viamedica.pl/neurologia_neurochirurgia_polska 415

Neurologia i Neurochirurgia Polska Polish Journal of Neurology and Neurosurgery 2021, Volume 55, no. 5, pages: 415–415 DOI: 10.5603/PJNNS.2021.0076 Copyright © 2021 Polish Neurological Society ISSN: 0028-3843, e-ISSN: 1897-4260

EDITORIAL NOTE

Address for correspondence: Zbigniew K. Wszolek, M.D., Department of Neurology, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL 32224, USA;

e-mail: wszolek.zbigniew@mayo.edu

Professor Jarosław Sławek elected Secretary

of the International Association of Parkinsonism and Related Disorders

Zbigniew K. Wszolek

1

, Łukasz Stolarczyk

2

1Co-Editor-in-Chief, Department of Neurology, Mayo Clinic Florida, Jacksonville, Florida, United States

2Journal Administrator, Via Medica™, Gdansk, Poland

With great pleasure, we announce that Professor Jarosław Sławek, Co-Editor-in-Chief of the Polish Journal of Neurology and Neurosurgery (PJNNS, Neurologia i Neurochirurgia Polska) has just been elected to the position of Secretary of the Inter- national Association of Parkinsonism and Related Disorders

(IAPRD). Prof. Sławek holds the positions of Professor of Neu- rology at the Medical University of Gdansk, Poland and Head of the Neurology & Stroke Department at the Saint Adalbert Hospital, also in Gdansk. Last month, he completed his four- year tenure as President of the Polish Neurological Society.

The IAPRD is a professional society of movement dis- orders specialists from around the world. It was formally incorporated in 2010, but the IAPRD has evolved from the earlier World Federation of Neurology Research Group on Parkinsonism and Related Disorders. IAPRD supports pub- lishing of two subspecialty journals, Parkinsonism & Related Disorders and Clinical Parkinsonism and Related Disorders.

The Association organises biannual international scientific and educational congresses, and holds teaching and educa- tional symposia / meetings in the years in between.

We wish Professor Sławek great success in his new inter- national position.

Cytaty

Pobierz teraz ( PDF - 1 Stron - 133.66 KB )

Powiązane dokumenty

The Voice of the Editor-in-Chief

Professor Janusz Gumprecht has excellently developed the journal — it appears regularly, contains more and more papers from outside Poland, is included in the Web of Science

The Voice of the Editor-in-Chief

Although more than 3,500 years have passed since the first description of the symptoms of diabetes in the Egyptian papyrus dated to around 1550 BC, diabetes is still

The Voice of the Editor-in-Chief

differences in the frequency, causes and duration of hospitalization of children with diabetes in different regions of Poland, which implies the need to ensure uniform access

The Voice of the Editor-in-Chief

Another challenge is effective and safe use of antidiabetic drugs to minimize side effects, improve adherence, increase the acceptance of the disease and reduce the risk

The Voice of the Editor-in-Chief

At the beginning of October, annual meeting of European Association for the Study of Diabetes (EASD) will be held in Berlin, and one of the most awaited events during this

THE VOICE OF THE EDITOR-IN-CHIEF

I would like to draw your attention to the problem of diabetes care quality discussed by researchers from Libya, an interesting case report of the use of hydroxychloroquine in type

The Voice of the Editor-in-Chief

Many interesting reports presented during the Congress addressed, among others, epidemiology, new possibilities of molecular biology, measurable effects of translating basic

The Voice of the Editor-in-Chief

Following the publication of the results of already completed Cardiovascular Outcome Trials (CVOTs) on new molecules used in the treatment of diabetes, there is no doubt that